CSF2 and neoplasm: Next, we investigated the effect of each treatment on myeloid-derived suppressor cell (MDSC) population within the tumor microenvironment, as high level of MDSC can abrogate the therapeutic benefit of DC vaccine and recombinant GM-CSF therapy has been reported to promote MDSC accumulation in the tumor tissues (35–39).